Combination Therapy in Pulmonary Arterial Hypertension: A Meta-Analysis
Authors:
- Lan SunLSLan Sun
- Shengshou HuSHShengshou Hu
- Yingjie WeiYWYingjie Wei
- 29 December 2011
- journal article
- research article
- Published by S. Karger AG in Cardiology
- Vol. 120 (3) , 157-165
Abstract
Objectives: It is unclear whether combination therapy is efficient and well tolerated in patients with pulmonary arterial hypertension (PAH). The objective was to analyze completed trials assessing the efficacy and safety of treating PAH with combination therapy. Methods: We performed a meta-analysis of all randomized controlled combination therapy trials that evaluated efficacy and safety in PAH patients. Trials were identified in the Cochrane Library, EMBASE and PubMed databases, reviews and reference lists of relevant papers. Results: Six trials with a total of 858 patients were included in the meta-analysis. Compared with the control group, combination therapy reduced clinical worsening [relative risk (RR) 0.48, 95% confidence interval (CI) 0.26–0.91, p = 0.023], increased the 6-min-walk distance significantly by 22.22 m, and reduced mean pulmonary arterial pressure, right atrial pressure and pulmonary vascular resistance. The incidence of serious adverse events was similar in the 2 groups (RR 1.17, 95% CI 0.40–3.42, p = 0.77). However, combination therapy did not influence mortality. Conclusions: Treatment of PAH with combination therapy improves multiple clinical and hemodynamic outcomes, but it has no effect on mortality. The long-term efficacy and safety of combination therapy in PAH requires further study based on large and rational-designed controlled clinical trials.Keywords
This publication has 29 references indexed in Scilit:
- Updated Clinical Classification of Pulmonary HypertensionJACC, 2009
- Medical Therapy for Pulmonary Arterial HypertensionChest, 2007
- Goal-oriented treatment and combination therapy for pulmonary arterial hypertensionEuropean Respiratory Journal, 2005
- Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004
- Introduction: new insights into a challenging diseaseJACC, 2004
- Cellular and molecular pathobiology of pulmonary arterial hypertensionJACC, 2004
- Endothelial Dysfunction in Pulmonary HypertensionCirculation, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?The Lancet, 1998
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986